Kyowa Hakko Bio is a Japanese leading company of bio-technology and fermentation. It was spun out from Kyowa Hakko Kogyo biochemical business unit and is a wholly owned subsidiary of Kyowa Hakko Kirin, Co., Ltd. Taking advantage of their state-of-the-art fermentation technologies, Kyowa Hakko has made substantial contributions to the health and well-being of people around the world by commercializing an array of useful chemical substances, including various amino acids, nucleic acid-related substances, vitamins, bioactive substances, pharmaceutical products, as well as oligosaccharides and dipeptides. In inheriting the valuable assets, manpower, and engineering prowess accumulated over 50 years since the invention of the glutamic acid fermentation process, and setting a high goal of "organically combining fermentation and synthesis" based on this legacy, the company is committed to developing a wide variety of innovative products, and providing medicines and dietary supplements for the better health and well-being of people worldwide.
Sumitomo Chemical has reached an agreement with Kyowa Hakko Bio Co., Ltd. to acquire Kyowa Hakko Bio’s plant growth regulator business.